ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 65 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $188,240 | -77.2% | 31,114 | -70.8% | 0.00% | -50.0% |
Q2 2023 | $827,332 | +234.3% | 106,615 | +145.5% | 0.00% | +100.0% |
Q1 2023 | $247,494 | -9.8% | 43,420 | -6.8% | 0.00% | 0.0% |
Q4 2022 | $274,291 | -50.8% | 46,569 | -73.2% | 0.00% | -50.0% |
Q3 2022 | $557,000 | -47.2% | 174,065 | -26.0% | 0.00% | -33.3% |
Q2 2022 | $1,054,000 | -38.2% | 235,336 | -26.3% | 0.00% | -40.0% |
Q1 2022 | $1,705,000 | +214.6% | 319,355 | +942.2% | 0.01% | +400.0% |
Q2 2021 | $542,000 | – | 30,641 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |